Global Gastrointestinal Cancer Devices Market Growth 2023-2029

February 2023 | 100 pages | ID: G432CE1F3C0CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Gastrointestinal cancer is the malignant condition that affects the gastrointestinal tract and the digestive system. This includes cancers of the liver, small intestine, esophagus, gall bladder, pancreas, anus, stomach, and bowel.

LPI (LP Information)' newest research report, the “Gastrointestinal Cancer Devices Industry Forecast” looks at past sales and reviews total world Gastrointestinal Cancer Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Cancer Devices sales for 2023 through 2029. With Gastrointestinal Cancer Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Cancer Devices industry.

This Insight Report provides a comprehensive analysis of the global Gastrointestinal Cancer Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Cancer Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gastrointestinal Cancer Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Cancer Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Cancer Devices.

The global Gastrointestinal Cancer Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Gastrointestinal Cancer Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gastrointestinal Cancer Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gastrointestinal Cancer Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gastrointestinal Cancer Devices players cover Eli Lilly, Roche, GlaxoSmithKline, Merck, Novartis, Otsuka Holdings, Stryker Corporation, Boston Scientific Corporation and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Cancer Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Surgery
  • Targeted Drugs Therapy
  • Chemo Therapy
  • Adjuvant Chemotherapy
  • Radiation Therapy
Segmentation by application
  • Hospitals
  • Clinics
  • Specialized Cancer Treatment Centers
  • Ambulatory Surgical Centers
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Eli Lilly
  • Roche
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Otsuka Holdings
  • Stryker Corporation
  • Boston Scientific Corporation
  • Johnson & Johnson
  • CONMED Corporation.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Gastrointestinal Cancer Devices market?

What factors are driving Gastrointestinal Cancer Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gastrointestinal Cancer Devices market opportunities vary by end market size?

How does Gastrointestinal Cancer Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gastrointestinal Cancer Devices Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Gastrointestinal Cancer Devices by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Gastrointestinal Cancer Devices by Country/Region, 2018, 2022 & 2029
2.2 Gastrointestinal Cancer Devices Segment by Type
  2.2.1 Surgery
  2.2.2 Targeted Drugs Therapy
  2.2.3 Chemo Therapy
  2.2.4 Adjuvant Chemotherapy
  2.2.5 Radiation Therapy
2.3 Gastrointestinal Cancer Devices Sales by Type
  2.3.1 Global Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
  2.3.2 Global Gastrointestinal Cancer Devices Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Gastrointestinal Cancer Devices Sale Price by Type (2018-2023)
2.4 Gastrointestinal Cancer Devices Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Specialized Cancer Treatment Centers
  2.4.4 Ambulatory Surgical Centers
2.5 Gastrointestinal Cancer Devices Sales by Application
  2.5.1 Global Gastrointestinal Cancer Devices Sale Market Share by Application (2018-2023)
  2.5.2 Global Gastrointestinal Cancer Devices Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Gastrointestinal Cancer Devices Sale Price by Application (2018-2023)

3 GLOBAL GASTROINTESTINAL CANCER DEVICES BY COMPANY

3.1 Global Gastrointestinal Cancer Devices Breakdown Data by Company
  3.1.1 Global Gastrointestinal Cancer Devices Annual Sales by Company (2018-2023)
  3.1.2 Global Gastrointestinal Cancer Devices Sales Market Share by Company (2018-2023)
3.2 Global Gastrointestinal Cancer Devices Annual Revenue by Company (2018-2023)
  3.2.1 Global Gastrointestinal Cancer Devices Revenue by Company (2018-2023)
  3.2.2 Global Gastrointestinal Cancer Devices Revenue Market Share by Company (2018-2023)
3.3 Global Gastrointestinal Cancer Devices Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Cancer Devices Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Gastrointestinal Cancer Devices Product Location Distribution
  3.4.2 Players Gastrointestinal Cancer Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR GASTROINTESTINAL CANCER DEVICES BY GEOGRAPHIC REGION

4.1 World Historic Gastrointestinal Cancer Devices Market Size by Geographic Region (2018-2023)
  4.1.1 Global Gastrointestinal Cancer Devices Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Gastrointestinal Cancer Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gastrointestinal Cancer Devices Market Size by Country/Region (2018-2023)
  4.2.1 Global Gastrointestinal Cancer Devices Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Gastrointestinal Cancer Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gastrointestinal Cancer Devices Sales Growth
4.4 APAC Gastrointestinal Cancer Devices Sales Growth
4.5 Europe Gastrointestinal Cancer Devices Sales Growth
4.6 Middle East & Africa Gastrointestinal Cancer Devices Sales Growth

5 AMERICAS

5.1 Americas Gastrointestinal Cancer Devices Sales by Country
  5.1.1 Americas Gastrointestinal Cancer Devices Sales by Country (2018-2023)
  5.1.2 Americas Gastrointestinal Cancer Devices Revenue by Country (2018-2023)
5.2 Americas Gastrointestinal Cancer Devices Sales by Type
5.3 Americas Gastrointestinal Cancer Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gastrointestinal Cancer Devices Sales by Region
  6.1.1 APAC Gastrointestinal Cancer Devices Sales by Region (2018-2023)
  6.1.2 APAC Gastrointestinal Cancer Devices Revenue by Region (2018-2023)
6.2 APAC Gastrointestinal Cancer Devices Sales by Type
6.3 APAC Gastrointestinal Cancer Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Gastrointestinal Cancer Devices by Country
  7.1.1 Europe Gastrointestinal Cancer Devices Sales by Country (2018-2023)
  7.1.2 Europe Gastrointestinal Cancer Devices Revenue by Country (2018-2023)
7.2 Europe Gastrointestinal Cancer Devices Sales by Type
7.3 Europe Gastrointestinal Cancer Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gastrointestinal Cancer Devices by Country
  8.1.1 Middle East & Africa Gastrointestinal Cancer Devices Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Gastrointestinal Cancer Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Gastrointestinal Cancer Devices Sales by Type
8.3 Middle East & Africa Gastrointestinal Cancer Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Devices
10.3 Manufacturing Process Analysis of Gastrointestinal Cancer Devices
10.4 Industry Chain Structure of Gastrointestinal Cancer Devices

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Gastrointestinal Cancer Devices Distributors
11.3 Gastrointestinal Cancer Devices Customer

12 WORLD FORECAST REVIEW FOR GASTROINTESTINAL CANCER DEVICES BY GEOGRAPHIC REGION

12.1 Global Gastrointestinal Cancer Devices Market Size Forecast by Region
  12.1.1 Global Gastrointestinal Cancer Devices Forecast by Region (2024-2029)
  12.1.2 Global Gastrointestinal Cancer Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastrointestinal Cancer Devices Forecast by Type
12.7 Global Gastrointestinal Cancer Devices Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Information
  13.1.2 Eli Lilly Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.1.3 Eli Lilly Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Eli Lilly Main Business Overview
  13.1.5 Eli Lilly Latest Developments
13.2 Roche
  13.2.1 Roche Company Information
  13.2.2 Roche Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.2.3 Roche Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Roche Main Business Overview
  13.2.5 Roche Latest Developments
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Information
  13.3.2 GlaxoSmithKline Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.3.3 GlaxoSmithKline Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 GlaxoSmithKline Main Business Overview
  13.3.5 GlaxoSmithKline Latest Developments
13.4 Merck
  13.4.1 Merck Company Information
  13.4.2 Merck Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.4.3 Merck Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Merck Main Business Overview
  13.4.5 Merck Latest Developments
13.5 Novartis
  13.5.1 Novartis Company Information
  13.5.2 Novartis Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.5.3 Novartis Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Novartis Main Business Overview
  13.5.5 Novartis Latest Developments
13.6 Otsuka Holdings
  13.6.1 Otsuka Holdings Company Information
  13.6.2 Otsuka Holdings Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.6.3 Otsuka Holdings Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Otsuka Holdings Main Business Overview
  13.6.5 Otsuka Holdings Latest Developments
13.7 Stryker Corporation
  13.7.1 Stryker Corporation Company Information
  13.7.2 Stryker Corporation Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.7.3 Stryker Corporation Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Stryker Corporation Main Business Overview
  13.7.5 Stryker Corporation Latest Developments
13.8 Boston Scientific Corporation
  13.8.1 Boston Scientific Corporation Company Information
  13.8.2 Boston Scientific Corporation Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.8.3 Boston Scientific Corporation Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Boston Scientific Corporation Main Business Overview
  13.8.5 Boston Scientific Corporation Latest Developments
13.9 Johnson & Johnson
  13.9.1 Johnson & Johnson Company Information
  13.9.2 Johnson & Johnson Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.9.3 Johnson & Johnson Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Johnson & Johnson Main Business Overview
  13.9.5 Johnson & Johnson Latest Developments
13.10 CONMED Corporation.
  13.10.1 CONMED Corporation. Company Information
  13.10.2 CONMED Corporation. Gastrointestinal Cancer Devices Product Portfolios and Specifications
  13.10.3 CONMED Corporation. Gastrointestinal Cancer Devices Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 CONMED Corporation. Main Business Overview
  13.10.5 CONMED Corporation. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Gastrointestinal Cancer Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gastrointestinal Cancer Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Surgery
Table 4. Major Players of Targeted Drugs Therapy
Table 5. Major Players of Chemo Therapy
Table 6. Major Players of Adjuvant Chemotherapy
Table 7. Major Players of Radiation Therapy
Table 8. Global Gastrointestinal Cancer Devices Sales by Type (2018-2023) & (K Units)
Table 9. Global Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
Table 10. Global Gastrointestinal Cancer Devices Revenue by Type (2018-2023) & ($ million)
Table 11. Global Gastrointestinal Cancer Devices Revenue Market Share by Type (2018-2023)
Table 12. Global Gastrointestinal Cancer Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Gastrointestinal Cancer Devices Sales by Application (2018-2023) & (K Units)
Table 14. Global Gastrointestinal Cancer Devices Sales Market Share by Application (2018-2023)
Table 15. Global Gastrointestinal Cancer Devices Revenue by Application (2018-2023)
Table 16. Global Gastrointestinal Cancer Devices Revenue Market Share by Application (2018-2023)
Table 17. Global Gastrointestinal Cancer Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Gastrointestinal Cancer Devices Sales by Company (2018-2023) & (K Units)
Table 19. Global Gastrointestinal Cancer Devices Sales Market Share by Company (2018-2023)
Table 20. Global Gastrointestinal Cancer Devices Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Gastrointestinal Cancer Devices Revenue Market Share by Company (2018-2023)
Table 22. Global Gastrointestinal Cancer Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Gastrointestinal Cancer Devices Producing Area Distribution and Sales Area
Table 24. Players Gastrointestinal Cancer Devices Products Offered
Table 25. Gastrointestinal Cancer Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Gastrointestinal Cancer Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Gastrointestinal Cancer Devices Sales Market Share Geographic Region (2018-2023)
Table 30. Global Gastrointestinal Cancer Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Gastrointestinal Cancer Devices Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Gastrointestinal Cancer Devices Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Gastrointestinal Cancer Devices Sales Market Share by Country/Region (2018-2023)
Table 34. Global Gastrointestinal Cancer Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Gastrointestinal Cancer Devices Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Gastrointestinal Cancer Devices Sales by Country (2018-2023) & (K Units)
Table 37. Americas Gastrointestinal Cancer Devices Sales Market Share by Country (2018-2023)
Table 38. Americas Gastrointestinal Cancer Devices Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Gastrointestinal Cancer Devices Revenue Market Share by Country (2018-2023)
Table 40. Americas Gastrointestinal Cancer Devices Sales by Type (2018-2023) & (K Units)
Table 41. Americas Gastrointestinal Cancer Devices Sales by Application (2018-2023) & (K Units)
Table 42. APAC Gastrointestinal Cancer Devices Sales by Region (2018-2023) & (K Units)
Table 43. APAC Gastrointestinal Cancer Devices Sales Market Share by Region (2018-2023)
Table 44. APAC Gastrointestinal Cancer Devices Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Gastrointestinal Cancer Devices Revenue Market Share by Region (2018-2023)
Table 46. APAC Gastrointestinal Cancer Devices Sales by Type (2018-2023) & (K Units)
Table 47. APAC Gastrointestinal Cancer Devices Sales by Application (2018-2023) & (K Units)
Table 48. Europe Gastrointestinal Cancer Devices Sales by Country (2018-2023) & (K Units)
Table 49. Europe Gastrointestinal Cancer Devices Sales Market Share by Country (2018-2023)
Table 50. Europe Gastrointestinal Cancer Devices Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Gastrointestinal Cancer Devices Revenue Market Share by Country (2018-2023)
Table 52. Europe Gastrointestinal Cancer Devices Sales by Type (2018-2023) & (K Units)
Table 53. Europe Gastrointestinal Cancer Devices Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Gastrointestinal Cancer Devices Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Gastrointestinal Cancer Devices Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gastrointestinal Cancer Devices Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Gastrointestinal Cancer Devices Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Gastrointestinal Cancer Devices Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Gastrointestinal Cancer Devices Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Gastrointestinal Cancer Devices
Table 61. Key Market Challenges & Risks of Gastrointestinal Cancer Devices
Table 62. Key Industry Trends of Gastrointestinal Cancer Devices
Table 63. Gastrointestinal Cancer Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Gastrointestinal Cancer Devices Distributors List
Table 66. Gastrointestinal Cancer Devices Customer List
Table 67. Global Gastrointestinal Cancer Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Gastrointestinal Cancer Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Gastrointestinal Cancer Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Gastrointestinal Cancer Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Gastrointestinal Cancer Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Gastrointestinal Cancer Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Gastrointestinal Cancer Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Gastrointestinal Cancer Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Gastrointestinal Cancer Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Gastrointestinal Cancer Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Gastrointestinal Cancer Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Gastrointestinal Cancer Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Gastrointestinal Cancer Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Gastrointestinal Cancer Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Eli Lilly Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Eli Lilly Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 83. Eli Lilly Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. Eli Lilly Main Business
Table 85. Eli Lilly Latest Developments
Table 86. Roche Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Roche Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 88. Roche Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Roche Main Business
Table 90. Roche Latest Developments
Table 91. GlaxoSmithKline Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 93. GlaxoSmithKline Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. GlaxoSmithKline Main Business
Table 95. GlaxoSmithKline Latest Developments
Table 96. Merck Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 98. Merck Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Novartis Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. Novartis Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 103. Novartis Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Otsuka Holdings Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. Otsuka Holdings Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 108. Otsuka Holdings Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. Otsuka Holdings Main Business
Table 110. Otsuka Holdings Latest Developments
Table 111. Stryker Corporation Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Stryker Corporation Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 113. Stryker Corporation Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Stryker Corporation Main Business
Table 115. Stryker Corporation Latest Developments
Table 116. Boston Scientific Corporation Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Corporation Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 118. Boston Scientific Corporation Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Boston Scientific Corporation Main Business
Table 120. Boston Scientific Corporation Latest Developments
Table 121. Johnson & Johnson Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. Johnson & Johnson Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 123. Johnson & Johnson Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Johnson & Johnson Main Business
Table 125. Johnson & Johnson Latest Developments
Table 126. CONMED Corporation. Basic Information, Gastrointestinal Cancer Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. CONMED Corporation. Gastrointestinal Cancer Devices Product Portfolios and Specifications
Table 128. CONMED Corporation. Gastrointestinal Cancer Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. CONMED Corporation. Main Business
Table 130. CONMED Corporation. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Gastrointestinal Cancer Devices
Figure 2. Gastrointestinal Cancer Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Cancer Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gastrointestinal Cancer Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gastrointestinal Cancer Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Surgery
Figure 10. Product Picture of Targeted Drugs Therapy
Figure 11. Product Picture of Chemo Therapy
Figure 12. Product Picture of Adjuvant Chemotherapy
Figure 13. Product Picture of Radiation Therapy
Figure 14. Global Gastrointestinal Cancer Devices Sales Market Share by Type in 2022
Figure 15. Global Gastrointestinal Cancer Devices Revenue Market Share by Type (2018-2023)
Figure 16. Gastrointestinal Cancer Devices Consumed in Hospitals
Figure 17. Global Gastrointestinal Cancer Devices Market: Hospitals (2018-2023) & (K Units)
Figure 18. Gastrointestinal Cancer Devices Consumed in Clinics
Figure 19. Global Gastrointestinal Cancer Devices Market: Clinics (2018-2023) & (K Units)
Figure 20. Gastrointestinal Cancer Devices Consumed in Specialized Cancer Treatment Centers
Figure 21. Global Gastrointestinal Cancer Devices Market: Specialized Cancer Treatment Centers (2018-2023) & (K Units)
Figure 22. Gastrointestinal Cancer Devices Consumed in Ambulatory Surgical Centers
Figure 23. Global Gastrointestinal Cancer Devices Market: Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 24. Global Gastrointestinal Cancer Devices Sales Market Share by Application (2022)
Figure 25. Global Gastrointestinal Cancer Devices Revenue Market Share by Application in 2022
Figure 26. Gastrointestinal Cancer Devices Sales Market by Company in 2022 (K Units)
Figure 27. Global Gastrointestinal Cancer Devices Sales Market Share by Company in 2022
Figure 28. Gastrointestinal Cancer Devices Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Gastrointestinal Cancer Devices Revenue Market Share by Company in 2022
Figure 30. Global Gastrointestinal Cancer Devices Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Gastrointestinal Cancer Devices Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Gastrointestinal Cancer Devices Sales 2018-2023 (K Units)
Figure 33. Americas Gastrointestinal Cancer Devices Revenue 2018-2023 ($ Millions)
Figure 34. APAC Gastrointestinal Cancer Devices Sales 2018-2023 (K Units)
Figure 35. APAC Gastrointestinal Cancer Devices Revenue 2018-2023 ($ Millions)
Figure 36. Europe Gastrointestinal Cancer Devices Sales 2018-2023 (K Units)
Figure 37. Europe Gastrointestinal Cancer Devices Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Gastrointestinal Cancer Devices Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Gastrointestinal Cancer Devices Revenue 2018-2023 ($ Millions)
Figure 40. Americas Gastrointestinal Cancer Devices Sales Market Share by Country in 2022
Figure 41. Americas Gastrointestinal Cancer Devices Revenue Market Share by Country in 2022
Figure 42. Americas Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
Figure 43. Americas Gastrointestinal Cancer Devices Sales Market Share by Application (2018-2023)
Figure 44. United States Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Gastrointestinal Cancer Devices Sales Market Share by Region in 2022
Figure 49. APAC Gastrointestinal Cancer Devices Revenue Market Share by Regions in 2022
Figure 50. APAC Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
Figure 51. APAC Gastrointestinal Cancer Devices Sales Market Share by Application (2018-2023)
Figure 52. China Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Gastrointestinal Cancer Devices Sales Market Share by Country in 2022
Figure 60. Europe Gastrointestinal Cancer Devices Revenue Market Share by Country in 2022
Figure 61. Europe Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
Figure 62. Europe Gastrointestinal Cancer Devices Sales Market Share by Application (2018-2023)
Figure 63. Germany Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Gastrointestinal Cancer Devices Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Gastrointestinal Cancer Devices Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Gastrointestinal Cancer Devices Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Gastrointestinal Cancer Devices Sales Market Share by Application (2018-2023)
Figure 72. Egypt Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Gastrointestinal Cancer Devices Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Gastrointestinal Cancer Devices in 2022
Figure 78. Manufacturing Process Analysis of Gastrointestinal Cancer Devices
Figure 79. Industry Chain Structure of Gastrointestinal Cancer Devices
Figure 80. Channels of Distribution
Figure 81. Global Gastrointestinal Cancer Devices Sales Market Forecast by Region (2024-2029)
Figure 82. Global Gastrointestinal Cancer Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Gastrointestinal Cancer Devices Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Gastrointestinal Cancer Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Gastrointestinal Cancer Devices Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Gastrointestinal Cancer Devices Revenue Market Share Forecast by Application (2024-2029)


More Publications